Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper.

Best practices for the management of local-regional recurrent chordoma : a position paper by the Chordoma Global Consensus Group / S. Stacchiotti, A. Gronchi, P. Fossati, T. Akiyama, C. Alapetite, M. Baumann, J.Y. Blay, S. Bolle, S. Boriani, P. Bruzzi, R. Capanna, A. Caraceni, R. Casadei, V. Colia, J. Debus, T. Delaney, A. Desai, P. Dileo, S. Dijkstra, F. Doglietto, A. Flanagan, S. Froelich, P.A. Gardner, H. Gelderblom, Z.L. Gokaslan, R. Haas, C. Heery, N. Hindi, P. Hohenberger, F. Hornicek, R. Imai, L. Jeys, R.L. Jones, B. Kasper, A. Kawai, M. Krengli, A. Leithner, I. Logowska, J. Martin Broto, D. Mazzatenta, C. Morosi, P. Nicolai, O.J. Norum, S. Patel, N. Penel, P. Picci, S. Pilotti, S. Radaelli, F. Ricchini, P. Rutkowski, S. Scheipl, C. Sen, E. Tamborini, K.A. Thornton, B. Timmermann, V. Torri, P.U. Tunn, M. Uhl, Y. Yamada, D.C. Weber, D. Vanel, P.P. Varga, C.L.A. Vleggeert-Lankamp, P.G. Casali, J. Sommer. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 28:6(2017), pp. 1230-1242. [10.1093/annonc/mdx054]

Best practices for the management of local-regional recurrent chordoma : a position paper by the Chordoma Global Consensus Group

S. Stacchiotti;P. Fossati;A. Caraceni;V. Colia;S. Radaelli;F. Ricchini;P.G. Casali;
2017

Abstract

Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper.
Chemotherapy; Chordoma; Radiotherapy; Relapse; Sarcoma; Surgery; Chordoma; Humans; Neoplasm Recurrence, Local; Practice Guidelines as Topic; Hematology; Oncology
Settore MED/06 - Oncologia Medica
Settore MED/18 - Chirurgia Generale
Settore MED/36 - Diagnostica per Immagini e Radioterapia
2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
mdx054.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 246.77 kB
Formato Adobe PDF
246.77 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/555632
Citazioni
  • ???jsp.display-item.citation.pmc??? 70
  • Scopus 163
  • ???jsp.display-item.citation.isi??? 145
social impact